Novavax is Developing Nanoparticle COVID-19 Vaccine

June 5, 2020

Novavax Inc.,* Gaithersburg, Maryland, was awarded a $21,952,384 cost-no-fee contract for the development and production of the Novavax nanoparticle vaccine against COVID-19. Bids were solicited via the internet with one received. Work will be performed in Gaithersburg, Maryland, with an estimated completion date of June 3, 2021. Fiscal 2020 Defense Health Agency Coronavirus Aid, Relief and Economic Security Act funds in the amount of $21,952,384 were obligated at the time of award. U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity (W911QY-20-C-0077). *Small Business

Enjoyed this article? SUBSCRIBE NOW to keep the content flowing.